Ed
Posted:
June 06, 2026
Location:
Field, Germany, Germany
Job Description
The Edwards Transcatheter Aortic Heart Valves unit (THV) consists of our SAPIEN family of transcatheter aortic and pulmonic heart valves which are the most widely prescribed transcatheter heart valves in the world!
Edwards leadership in transcatheter heart valve replacement includes a commitment to meaningful innovation, rigorous scientific study, extensive clinician training and education, and significant investment in new applications of the technology. The Edwards SAPIEN valve platform continues to raise the bar as the most widely studied transcatheter heart valve worldwide.
The **Country Marketing Director Germany** is accountable for defining and leading the country marketing strategy to drive sustainable business growth and value differentiation in **Germany** . This role provides senior marketing leadership at country level, translates European strategy into impactful local execution, and ensures strong cross-functional alignment. As a member of the **THV G...
Edwards leadership in transcatheter heart valve replacement includes a commitment to meaningful innovation, rigorous scientific study, extensive clinician training and education, and significant investment in new applications of the technology. The Edwards SAPIEN valve platform continues to raise the bar as the most widely studied transcatheter heart valve worldwide.
The **Country Marketing Director Germany** is accountable for defining and leading the country marketing strategy to drive sustainable business growth and value differentiation in **Germany** . This role provides senior marketing leadership at country level, translates European strategy into impactful local execution, and ensures strong cross-functional alignment. As a member of the **THV G...
Apply for this Job
Submit your application for the Director, Marketing THV - Germany position at Edwards Lifesciences.
Apply Now Save for LaterJob Overview
Job Type:
Full-time
Location:
Field, Germany
Posted:
June 06, 2026
Deadline:
June 13, 2026